» Authors » Aparna H Kesarwala

Aparna H Kesarwala

Explore the profile of Aparna H Kesarwala including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 863
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Patel J, McCall N, Thomas M, Zhou J, Higgins K, Bradley J, et al.
Int J Part Ther . 2024 Jun; 12:100016. PMID: 38832321
Purpose: Emerging data have illuminated the impact of effective radiation dose to immune cells (EDIC) on outcomes in patients with locally advanced, unresectable non-small cell lung cancer (NSCLC) treated with...
12.
Abouei E, Pan S, Hu M, Kesarwala A, Qiu R, Zhou J, et al.
Phys Med Biol . 2024 May; 69(11). PMID: 38744300
. In this work, we proposed a deep-learning segmentation algorithm for cardiac magnetic resonance imaging to aid in contouring of the left ventricle, right ventricle, and Myocardium (Myo).We proposed a...
13.
Shen Y, Connolly E, Aiello M, Zhou C, Chappa P, Song H, et al.
Res Sq . 2024 Mar; PMID: 38496632
Radiotherapy (RT) and anti-PD-L1 synergize to enhance local and distant (abscopal) tumor control. However, clinical results in humans have been variable. With the goal of improving clinical outcomes, we investigated...
14.
Matkovic L, Lei Y, Fu Y, Wang T, Kesarwala A, Axente M, et al.
Med Phys . 2023 Sep; 51(3):1974-1984. PMID: 37708440
Background: An automated, accurate, and efficient lung four-dimensional computed tomography (4DCT) image registration method is clinically important to quantify respiratory motion for optimal motion management. Purpose: The purpose of this...
15.
McCall N, Janopaul-Naylor J, McGinnis H, Kesarwala A, Tian S, Stokes W, et al.
Cancer . 2023 Jun; 129(23):3713-3723. PMID: 37354070
Background: The PACIFIC trial established consolidative durvalumab after concurrent chemoradiation as standard-of-care in patients with stage III or unresectable non-small cell lung cancer (NSCLC). Black patients, however, comprised just 2%...
16.
Lei Y, Tian Z, Wang T, Roper J, Xie H, Kesarwala A, et al.
Med Phys . 2023 Mar; 50(9):5518-5527. PMID: 36939395
Purpose: The long acquisition time of CBCT discourages repeat verification imaging, therefore increasing treatment uncertainty. In this study, we present a fast volumetric imaging method for lung cancer radiation therapy...
17.
Findlay S, Nair R, Merrill R, Kaiser Z, Cajelot A, Aryanpour Z, et al.
Blood Adv . 2023 Mar; 7(14):3485-3500. PMID: 36920785
Multiple myeloma (MM) is a hematological malignancy that emerges from antibody-producing plasma B cells. Proteasome inhibitors, including the US Food and Drug Administration-approved bortezomib (BTZ) and carfilzomib (CFZ), are frequently...
18.
Janopaul-Naylor J, Cao Y, McCall N, Switchenko J, Tian S, Chen H, et al.
Front Oncol . 2023 Feb; 12:1074675. PMID: 36733369
Introduction: As immunotherapy has improved distant metastasis-free survival (DMFS) in Non-Small Cell Lung Cancer (NSCLC), isolated locoregional recurrences have increased. However, management of locoregional recurrences can be challenging. We report...
19.
Hertel N, Biegalski S, Nelson V, Nelson W, Mukhopadhyay S, Su Z, et al.
Life Sci Space Res (Amst) . 2022 Nov; 35:163-169. PMID: 36336362
Implementation of a systematic program for galactic cosmic radiation (GCR) countermeasure discovery will require convenient access to ground-based space radiation analogs. The current gold standard approach for GCR simulation is...
20.
Lei Y, Wang T, Jeong J, Janopaul-Naylor J, Kesarwala A, Roper J, et al.
Med Phys . 2022 Oct; 50(1):274-283. PMID: 36203393
Background: Multimodality positron emission tomography/computed tomography (PET/CT) imaging combines the anatomical information of CT with the functional information of PET. In the diagnosis and treatment of many cancers, such as...